Aurinia Pharmaceuticals Inc. achieved record Lupkynis sales of $66.6M in Q2 while managing cash flow. Click for insights on ...

Providence researchers discuss their recently published results on the impact of ambient clinical intelligence on ...

Neurocrine Biosciences continues strong with Ingrezza and Crenessity growth, plus a promising pipeline in MDD and ...

YoungBoy Never Broke Again is back full throttle with his new album MASA.

As shown in Table 1, trial characteristics, including ethical approval statement, consent, description of participant recruitment, reporting of dropouts, use of a study flow chart and data-sharing ...